Track the Cresco Labs Inc. share price and the full management transaction log of the company, a listed issuer based in Canada. Shares trade on CA CA, under the oversight of SEDI. Operating in the Health Care sector, Cresco Labs Inc. has logged 16 public disclosures. Market capitalisation: €371m. The latest transaction was disclosed on 17 June 2026 (10 - Acquisition or disposition in the public market). Among the most active insiders: Butler, Gregory Randolph. All data is free.
16
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
23Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,919 of 27,989 companies
29.3
score / 100
Value
31
Quality
28
FCF yld10%
Earn yld-41%
EV/EBITDA45.1x
ROE-46%
Gross mgn49%
Net mgn-21%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
263 shares@ CA$0.905.4% of flowSubordinate Voting SharesTSXSEDI:4724165
Canonical exit: 24 Aug 2026 (T+90)
16 of 16 declarations
About Cresco Labs Inc.
Cresco Labs Inc. is a company in the health and pharmaceutical sector, focused on the production and distribution of cannabis-based products. It is listed on the Toronto Stock Exchange (XTSE).